» Articles » PMID: 29960098

High Rate of Clostridium Difficile Among Young Adults Presenting with Diarrhea at Two Hospitals in Kenya

Overview
Publisher Elsevier
Date 2018 Jul 1
PMID 29960098
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Clostridium difficile infection (CDI) is the leading cause of antibiotic-associated diarrhea worldwide. As a result, the US Centers for Disease Control and Prevention have designated C. difficile as an urgent threat. Despite the global public health risk posed by CDI, little is known about its epidemiology on the African continent. This article describes the common occurrence of CDI from a cross-section of consecutively seen, randomly enrolled patients presenting with diarrhea at two major hospitals in Kenya.

Methods: Patients presenting with diarrhea at two major hospitals in Kenya from May to July 2017 were enrolled. After signing the informed consent, stool samples, demographic data, medical history, prior antibiotic use, and HIV status were obtained from the patients. C. difficile was detected and validated by toxigenic culture and PCR.

Results: The average age of the patients was 35.5 years (range 3-86 years); 59% were male and 41% were female. Out of 105 patient stools tested, 98 (93.3%) were positive for C. difficile by culture. PCR analysis confirmed C. difficile-specific genes, tcdA, tcdB, and tcdC, in the strains isolated from the stools. Further, 82.5% of the stools had C. difficile isolates bearing the frame-shift deletion associated with hypervirulent strains. Remarkably, 91.9% of the stools that tested positive for C. difficile came from patients under 60 years old, with 64.3% being less than 40 years of age. The majority of the patients (85%) reported over-the-counter antibiotic use in the last 30days before the hospital visit.

Conclusions: Together, the results revealed an unusually high incidence of C. difficile in the stools analyzed, especially among young adults who are thought to be less vulnerable. Comprehensive research is urgently needed to examine the epidemiology, risk factors, pathogenesis, comorbidities, clinical outcomes, antibiotic susceptibility, and genetic makeup of C. difficile strains circulating on the African continent.

Citing Articles

Best Practices in the Management of Infection in Developing Nations.

Mendo-Lopez R, Alonso C, Villafuerte-Galvez J Trop Med Infect Dis. 2024; 9(8).

PMID: 39195623 PMC: 11359346. DOI: 10.3390/tropicalmed9080185.


Pediatric diarrhea patients living in urban areas have a higher incidence of Clostridioides difficile infection.

Adesoji A, Mgbere O, Darkoh C PLOS Glob Public Health. 2023; 3(1):e0000477.

PMID: 36962940 PMC: 10022077. DOI: 10.1371/journal.pgph.0000477.


Assessment of independent comorbidities and comorbidity measures in predicting healthcare facility-onset Clostridioides difficile infection in Kenya.

Mutai W, Mureithi M, Anzala O, Kullin B, Ofwete R, Kyany A C PLOS Glob Public Health. 2023; 2(1):e0000090.

PMID: 36962261 PMC: 10022263. DOI: 10.1371/journal.pgph.0000090.


Emergence of Clinical Clostridioides difficile Isolates With Decreased Susceptibility to Vancomycin.

Darkoh C, Keita K, Odo C, Oyaro M, Brown E, Arias C Clin Infect Dis. 2022; 74(1):120-126.

PMID: 35016207 PMC: 8752249. DOI: 10.1093/cid/ciaa912.


High Prevalence of Multidrug-Resistant Following Extensive Use of Antimicrobials in Hospitalized Patients in Kenya.

Mutai W, Mureithi M, Anzala O, Revathi G, Kullin B, Burugu M Front Cell Infect Microbiol. 2021; 10:604986.

PMID: 33628744 PMC: 7897694. DOI: 10.3389/fcimb.2020.604986.


References
1.
Li N, Jia H, Yang H, Ji B, Liu Y, Peng X . Preliminary screening of type IV secretion system in divergent geographic sources of . Exp Ther Med. 2017; 14(5):4405-4410. PMC: 5658759. DOI: 10.3892/etm.2017.5065. View

2.
Onwueme K, Fadairo Y, Idoko L, Onuh J, Alao O, Agaba P . High prevalence of toxinogenic Clostridium difficile in Nigerian adult HIV patients. Trans R Soc Trop Med Hyg. 2011; 105(11):667-9. DOI: 10.1016/j.trstmh.2011.07.014. View

3.
Matamouros S, England P, Dupuy B . Clostridium difficile toxin expression is inhibited by the novel regulator TcdC. Mol Microbiol. 2007; 64(5):1274-88. DOI: 10.1111/j.1365-2958.2007.05739.x. View

4.
Fiedoruk K, Daniluk T, Rozkiewicz D, Zaremba M, Oldak E, Sciepuk M . Conventional and molecular methods in the diagnosis of community-acquired diarrhoea in children under 5 years of age from the north-eastern region of Poland. Int J Infect Dis. 2015; 37:145-51. DOI: 10.1016/j.ijid.2015.06.028. View

5.
Fry P, Thakur S, Abley M, Gebreyes W . Antimicrobial resistance, toxinotype, and genotypic profiling of Clostridium difficile isolates of swine origin. J Clin Microbiol. 2012; 50(7):2366-72. PMC: 3405606. DOI: 10.1128/JCM.06581-11. View